A new gene therapy offers hope for the millions of people around the world afflicted with Alzheimer&#x27;s Disease. The treatment works by blocking the formation of amyloid-beta peptide, which is the main component of amyloid plaques, the sticky clumps of protein found in the brains of people with Alzheimer’s disease. These plaques are thought to trigger the death of brain cells.